Elias AD - Search Results

1

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, Baum CM, Miller KD. Burstein HJ, et al. Among authors: elias ad. J Clin Oncol. 2008 Apr 10;26(11):1810-6. doi: 10.1200/JCO.2007.14.5375. Epub 2008 Mar 17. J Clin Oncol. 2008. PMID: 18347007 Clinical Trial.

2

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C, Eder JP, Rosowsky A, Antman K, Frei E 3rd. Ayash LJ, et al. J Clin Oncol. 1992 Jun;10(6):995-1000. doi: 10.1200/JCO.1992.10.6.995. J Clin Oncol. 1992. PMID: 1588381

3

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, et al. Antman K, et al. J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102. J Clin Oncol. 1992. PMID: 1727912 Clinical Trial.

4

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Hunt M, Critchlow J, Schnipper L, Frei E 3rd, et al. Elias AD, et al. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S208-13. doi: 10.1007/BF01613229. J Cancer Res Clin Oncol. 1991. PMID: 1795009 Clinical Trial.

5

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al. Elias AD, et al. J Clin Oncol. 1991 Feb;9(2):320-7. doi: 10.1200/JCO.1991.9.2.320. J Clin Oncol. 1991. PMID: 1846407 Clinical Trial.

6

High-dose ifosfamide with mesna uroprotection: a phase I study.

Elias AD, Eder JP, Shea T, Begg CB, Frei E 3rd, Antman KH. Elias AD, et al. J Clin Oncol. 1990 Jan;8(1):170-8. doi: 10.1200/JCO.1990.8.1.170. J Clin Oncol. 1990. PMID: 2104923

7

Dana-Farber Cancer Institute studies in advanced sarcoma.

Antman KH, Elias A. Antman KH, et al. Semin Oncol. 1990 Feb;17(1 Suppl 2):7-15. Semin Oncol. 1990. PMID: 2106162 Clinical Trial.

8

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

Eder JP, Elias A, Shea TC, Schryber SM, Teicher BA, Hunt M, Burke J, Siegel R, Schnipper LE, Frei E 3rd, et al. Eder JP, et al. J Clin Oncol. 1990 Jul;8(7):1239-45. doi: 10.1200/JCO.1990.8.7.1239. J Clin Oncol. 1990. PMID: 2162912

9

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.

Ayash LJ, Hunt M, Antman K, Nadler L, Wheeler C, Takvorian T, Elias A, Antin JH, Greenough T, Eder JP. Ayash LJ, et al. J Clin Oncol. 1990 Oct;8(10):1699-706. doi: 10.1200/JCO.1990.8.10.1699. J Clin Oncol. 1990. PMID: 2213105

10

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

Antman KH, Ryan L, Elias A, Sherman D, Grier HE. Antman KH, et al. J Clin Oncol. 1989 Jan;7(1):126-31. doi: 10.1200/JCO.1989.7.1.126. J Clin Oncol. 1989. PMID: 2491883 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters